Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1989-8-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0008-9176
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
290-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3252981-Antibodies, Viral,
pubmed-meshheading:3252981-Female,
pubmed-meshheading:3252981-Humans,
pubmed-meshheading:3252981-Infant,
pubmed-meshheading:3252981-Male,
pubmed-meshheading:3252981-Poliomyelitis,
pubmed-meshheading:3252981-Poliovirus Vaccine, Oral,
pubmed-meshheading:3252981-Zimbabwe
|
pubmed:year |
1988
|
pubmed:articleTitle |
Sero-conversion of infants to three doses of oral poliomyelitis vaccine.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|